A Prospective Study of the Early Treatment of Recombinant Human Thrombopoietin for Chemoradiation Induced Thrombocytopenia in Cervical Squamous Cell Carcinoma Patient

NCT07649395 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
75
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mei Feng